SBC Medicals Income from Continuous Operations 2023-2024 | SBC
SBC Medicals income from continuous operations from 2023 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
| SBC Medicals Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2023 | $0 |
| 2022 | $1 |
| SBC Medicals Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024-06-30 | $-0 |
| 2024-03-31 | $-0 |
| 2023-12-31 | $-0 |
| 2023-09-30 | $-0 |
| 2023-06-30 | $0 |
| 2023-03-31 | $1 |
| 2022-12-31 | |
| 2022-09-30 | $-0 |
| 2022-06-30 | $-0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.717B | $0.000B |
| SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand. SBC Medical Group Holdings Incorporated, formerly known as Pono Capital Two Inc., is based in TOKYO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $95.295B | 11.82 |
| Cencora (COR) | United States | $49.256B | 18.17 |
| DiDi Global (DIDIY) | China | $23.330B | 0.00 |
| Natera (NTRA) | United States | $21.251B | 0.00 |
| ICON (ICLR) | Ireland | $16.821B | 14.98 |
| Viatris (VTRS) | United States | $15.517B | 4.78 |
| Avantor (AVTR) | United States | $14.688B | 22.02 |
| Revvity (RVTY) | United States | $14.573B | 25.32 |
| BioMerieux (BMXMF) | France | $12.666B | 0.00 |
| CochLear (CHEOY) | Australia | $12.640B | 0.00 |
| Solventum (SOLV) | United States | $12.100B | 0.00 |
| Medpace Holdings (MEDP) | United States | $11.250B | 31.69 |
| Charles River Laboratories (CRL) | United States | $10.562B | 20.41 |
| Doximity (DOCS) | United States | $9.814B | 58.09 |
| HealthEquity (HQY) | United States | $8.278B | 44.93 |
| Sonic Healthcare (SKHHY) | Australia | $8.023B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.959B | 32.39 |
| Life Times (LTH) | United States | $5.005B | 33.12 |
| Sotera Health (SHC) | United States | $4.339B | 23.21 |
| Organon (OGN) | United States | $4.020B | 4.05 |
| BrightSpring Health Services (BTSG) | United States | $3.423B | 72.82 |
| Surgery Partners (SGRY) | United States | $3.242B | 36.96 |
| PACS (PACS) | United States | $3.123B | 0.00 |
| Concentras Parent (CON) | United States | $2.623B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.450B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.426B | 0.00 |
| Premier (PINC) | United States | $2.317B | 11.56 |
| GeneDx Holdings (WGS) | United States | $2.156B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.768B | 46.60 |
| Teladoc Health (TDOC) | United States | $1.648B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.307B | 12.79 |
| CareDx (CDNA) | United States | $1.222B | 0.00 |
| Progyny (PGNY) | United States | $1.184B | 23.97 |
| Establishment Labs Holdings (ESTA) | $1.101B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.937B | 6.34 |
| Embecta (EMBC) | United States | $0.889B | 5.92 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| Agilon Health (AGL) | United States | $0.775B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.741B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.516B | 0.00 |
| DocGo (DCGO) | United States | $0.433B | 16.27 |
| Sonida Senior Living (SNDA) | United States | $0.419B | 0.00 |
| Enhabit (EHAB) | United States | $0.383B | 33.09 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.341B | 0.00 |
| LifeMD (LFMD) | United States | $0.303B | 0.00 |
| ModivCare (MODV) | United States | $0.241B | 13.05 |
| Sera Prognostics (SERA) | United States | $0.233B | 0.00 |
| Beauty Health (SKIN) | United States | $0.229B | 0.00 |
| Biodesix (BDSX) | United States | $0.204B | 0.00 |
| Nutex Health (NUTX) | United States | $0.177B | 0.00 |
| MultiPlan (MPLN) | United States | $0.133B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.120B | 0.00 |
| So-Young (SY) | China | $0.083B | 19.99 |
| Singular Genomics Systems (OMIC) | United States | $0.057B | 0.00 |
| OncoCyte (OCX) | United States | $0.050B | 0.00 |
| NeueHealth (NEUE) | United States | $0.039B | 1.02 |
| Co-Diagnostics (CODX) | United States | $0.035B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.028B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.025B | 0.00 |
| Oncology Institute (TOI) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| KindlyMD (KDLY) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |